Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward

Chronic obstructive pulmonary disease (COPD) is the end result of a series of dynamic and cumulative gene-environment interactions over a lifetime. The evolving understanding of COPD biology provides novel opportunities for prevention, early diagnosis, and intervention. To advance these concepts, we propose therapeutic trials in two major groups of subjects: «young» individuals with COPD and those with pre-COPD.
Puedes acceder al artículo completo en este enlace: https://pubmed.ncbi.nlm.nih.gov/34672872/
Autores: Fernando J Martinez, Alvar Agusti, Bartolome R Celli, MeiLan K Han, James P Allinson, Surya P Bhatt, Peter Calverley, Sanjay H Chotirmall, Badrul Chowdhury, Patrick Darken, Carla A Da Silva, Gavin Donaldson, Paul Dorinsky, Mark Dransfield, Rosa Faner, David M Halpin, Paul Jones, Jerry A Krishnan, Nicholas Locantore, Fernando D Martinez, Hana Mullerova, David Price, Klaus F Rabe, Colin Reisner, Dave Singh, Jørgen Vestbo, Claus F Vogelmeier, Robert A Wise, Ruth Tal-Singer, Jadwiga A Wedzicha.
Noticias relacionadas

Nueva Normativa GOLD 2023
La nueva normativa GOLD 2023, el slide set y la pocket guide ya están disponibles gratis para descargar

Vídeo de Presentación de Novedades GOLD el 23 de Noviembre de 2022 (17-19h)
Vídeo de la Presentación de las Novedades Gold 2023 del 23 de Noviembre de 2022, de 17 a 19h, presentado y moderado por El Dr. Alvar Agustí.
Más artículos
COPD
- Leonardo M Fabbri et al. COPD and multimorbidity: recognising and addressing a syndemic occurrence
- Singh D, Criner GJ, Agustí A et al. Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
- Alvar Agusti, M.D., Ph.D. – Biologics for COPD — Finally Here
- D. Pellegrino, S. Casas-Recasens, R. Faner, P. Palange, A. Agusti. When GETomics meets aging and exercise in COPD
- Alvar Agustí et al.- GOLD 2023: What’s New, Doc?
EPOC
- Leonardo M Fabbri et al. COPD and multimorbidity: recognising and addressing a syndemic occurrence
- Singh D, Criner GJ, Agustí A et al. Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
- Alvar Agusti, M.D., Ph.D. – Biologics for COPD — Finally Here
- D. Pellegrino, S. Casas-Recasens, R. Faner, P. Palange, A. Agusti. When GETomics meets aging and exercise in COPD
- Alvar Agustí et al.- GOLD 2023: What’s New, Doc?
Recuerda que puedes acceder a varios enlaces a artículos en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imágenes obtenidas el 27/01/2023 de la aplicación Canva Pro.